Abstract: Various methods and systems are provided for spectral computed tomography (CT) imaging. In one embodiment, a method comprises performing a scan of a subject to acquire, with a detector array comprising a plurality of detector elements, projection data of the subject, generating corrected path-length estimates based on the projection data and one or more selected correction functions, and reconstructing at least one material density image based on the corrected path-length estimates. In this way, the fidelity of spectral information is improved, thereby increasing image quality for spectral computed tomography (CT) imaging systems, especially those configured with photon-counting detectors.

Abstract: Various methods and systems are provided for spectral computed tomography (CT) imaging. In one embodiment, a method comprises performing a scan of a subject to acquire, with a detector array comprising a plurality of detector elements, projection data of the subject, generating corrected path-length estimates based on the projection data and one or more selected correction functions, and reconstructing at least one material density image based on the corrected path-length estimates. In this way, the fidelity of spectral information is improved, thereby increasing image quality for spectral computed tomography (CT) imaging systems, especially those configured with photon-counting detectors.

Abstract: Methods and systems for performing optogenetics using X-rays or ultrasound waves are provided. Visible-light-emitting nanophosphors can be provided to a sample, and X-ray stimulation can be used to stimulate the nanophosphors to emit visible light. Alternatively, ultrasonic waves can be provided to the sample to cause sonoluminescence, also resulting in emission of visible light, and this can be aided by the use of a chemiluminescent agent present in the sample. The emitted light can trigger changes in proteins that modulate membrane potentials in neuronal cells.

Abstract: Methods and systems for performing optogenetics using X-rays or ultrasound waves are provided. Visible-light-emitting nanophosphors can be provided to a sample, and X-ray stimulation can be used to stimulate the nanophosphors to emit visible light. Alternatively, ultrasonic waves can be provided to the sample to cause sonoluminescence, also resulting in emission of visible light, and this can be aided by the use of a chemiluminescent agent present in the sample. The emitted light can trigger changes in proteins that modulate membrane potentials in neuronal cells.

Abstract: Methods and systems for performing optogenetics using X-rays or ultrasound waves are provided. Visible-light-emitting nanophosphors can be provided to a sample, and X-ray stimulation can be used to stimulate the nanophosphors to emit visible light. Alternatively, ultrasonic waves can be provided to the sample to cause sonoluminescence, also resulting in emission of visible light, and this can be aided by the use of a chemiluminescent agent present in the sample. The emitted light can trigger changes in proteins that modulate membrane potentials in neuronal cells.